Atrium Therapeutics Inc (RNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Sales | 1,573 | 2,973 | 2,336 | 2,045 | 3,543 |
| Gross Profit | 1,573 | 2,973 | 2,336 | 2,045 | 3,543 |
| Operating Expenses | 9,025 | 28,338 | 23,273 | 20,731 | 13,898 |
| Operating Income | -7,452 | -25,365 | -20,937 | -18,686 | -10,355 |
| Other Income | 3 | -76,891 | -59,461 | -52,107 | -58,500 |
| Pre-tax Income | -7,449 | -102,256 | -80,398 | -70,793 | -68,855 |
| Net Income Continuous | -7,449 | -102,256 | -80,398 | -70,793 | -68,855 |
| Net Income | $-7,449 | $-102,256 | $-80,398 | $-70,793 | $-68,855 |
| EPS Basic Total Ops | -0.44 | N/A | N/A | N/A | N/A |
| EPS Basic Continuous Ops | -0.44 | N/A | N/A | N/A | N/A |
| EPS Diluted Total Ops | -0.44 | N/A | N/A | N/A | N/A |
| EPS Diluted Continuous Ops | -0.44 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-7,399 | $-25,365 | $-20,937 | $-18,686 | $-10,355 |